GR871289B - Novel galenical formulations - Google Patents

Novel galenical formulations

Info

Publication number
GR871289B
GR871289B GR871289A GR870101289A GR871289B GR 871289 B GR871289 B GR 871289B GR 871289 A GR871289 A GR 871289A GR 870101289 A GR870101289 A GR 870101289A GR 871289 B GR871289 B GR 871289B
Authority
GR
Greece
Prior art keywords
galenical formulations
novel galenical
novel
formulations
galenical
Prior art date
Application number
GR871289A
Other languages
Greek (el)
English (en)
Inventor
Moise Dr Azria
Thomas Dr Cavanak
Wolfgang Dr Doepfner
Rummelt Dr Andreas
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868620035A external-priority patent/GB8620035D0/en
Priority claimed from GB868626821A external-priority patent/GB8626821D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of GR871289B publication Critical patent/GR871289B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
GR871289A 1986-08-18 1987-08-17 Novel galenical formulations GR871289B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868620035A GB8620035D0 (en) 1986-08-18 1986-08-18 Organic compounds
GB868626821A GB8626821D0 (en) 1986-11-10 1986-11-10 Organic compounds

Publications (1)

Publication Number Publication Date
GR871289B true GR871289B (en) 1987-12-18

Family

ID=26291187

Family Applications (1)

Application Number Title Priority Date Filing Date
GR871289A GR871289B (en) 1986-08-18 1987-08-17 Novel galenical formulations

Country Status (24)

Country Link
KR (1) KR880002537A (fr)
AT (1) AT396331B (fr)
AU (2) AU612589B2 (fr)
BE (1) BE1001748A4 (fr)
CA (1) CA1322331C (fr)
CH (1) CH672252A5 (fr)
CS (1) CS411491A3 (fr)
DE (1) DE3726517A1 (fr)
DK (1) DK428287A (fr)
ES (1) ES2004807A6 (fr)
FI (1) FI93307C (fr)
FR (1) FR2602680B1 (fr)
GR (1) GR871289B (fr)
HK (1) HK80493A (fr)
HU (1) HU200940B (fr)
IE (1) IE60761B1 (fr)
IL (1) IL83572A (fr)
IT (1) IT1222510B (fr)
LU (1) LU86971A1 (fr)
NL (1) NL8701874A (fr)
NO (1) NO175519C (fr)
NZ (1) NZ221473A (fr)
PT (1) PT85545B (fr)
SE (1) SE8703183L (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003061592A2 (fr) 2002-01-22 2003-07-31 New York University Methodes de traitement therapeutique de l'hypertrophie benigne de la prostate (bph)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
ATE2512T1 (de) * 1979-11-27 1983-03-15 Sandoz Ag Polypeptide, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen, die diese polypeptide enthalten, und ihre verwendung.
US4451394A (en) * 1982-10-25 1984-05-29 American Home Products Corporation Dodecapeptides preventing glucose and triglyceride assimilation
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4505897A (en) * 1983-04-18 1985-03-19 The Administrators Of The Tulane Educational Fund Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
JPS60224616A (ja) * 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体

Also Published As

Publication number Publication date
AU637530B2 (en) 1993-05-27
AT396331B (de) 1993-08-25
FI873548A (fi) 1988-02-19
IL83572A (en) 1992-09-06
KR880002537A (ko) 1988-05-09
FI873548A0 (fi) 1987-08-17
NL8701874A (nl) 1988-03-16
NZ221473A (en) 1990-08-28
PT85545B (pt) 1990-05-31
NO175519C (no) 1994-10-26
HUT46235A (en) 1988-10-28
IT8721670A0 (it) 1987-08-18
AU612589B2 (en) 1991-07-18
IE60761B1 (en) 1994-08-10
DE3726517A1 (de) 1988-03-03
HK80493A (en) 1993-08-13
FR2602680A1 (fr) 1988-02-19
CS411491A3 (en) 1992-06-17
DK428287D0 (da) 1987-08-17
IE872187L (en) 1988-02-18
NO873452D0 (no) 1987-08-17
BE1001748A4 (fr) 1990-02-27
NO175519B (no) 1994-07-18
PT85545A (en) 1987-09-01
IT1222510B (it) 1990-09-05
SE8703183L (sv) 1988-02-19
HU200940B (en) 1990-09-28
LU86971A1 (fr) 1988-03-02
FR2602680B1 (fr) 1993-04-16
IL83572A0 (en) 1988-01-31
FI93307B (fi) 1994-12-15
ES2004807A6 (es) 1989-02-01
AU7712087A (en) 1988-02-25
CH672252A5 (fr) 1989-11-15
DK428287A (da) 1988-02-19
CA1322331C (fr) 1993-09-21
SE8703183D0 (sv) 1987-08-17
FI93307C (fi) 1995-03-27
AU8568991A (en) 1991-12-05
NO873452L (no) 1988-02-19
ATA206087A (de) 1992-12-15

Similar Documents

Publication Publication Date Title
GB8628359D0 (en) Galenical formulation
GB8613914D0 (en) Liquid formulations
PT85468A (en) Pharmaceutical formulations
GB8719248D0 (en) Galenical formulations
GB8613196D0 (en) Compositions
ZA876119B (en) Novel galenical formulations
GR871289B (en) Novel galenical formulations
GB8601048D0 (en) Compositions
GR871915B (en) Pharmaceutical formulations
GB8606755D0 (en) Formulations
GB8606455D0 (en) Formulations
GB8630713D0 (en) Compositions
GB8621018D0 (en) Formulation
GB8621228D0 (en) Formulation
GB8606259D0 (en) Formulation
GB8614980D0 (en) Formulation
GB8630907D0 (en) Formulation
GB8628604D0 (en) Formulation
GB8628603D0 (en) Formulation
GB8624268D0 (en) Formulation
GB8621448D0 (en) Formulation
GB8621019D0 (en) Formulation
GB8606403D0 (en) Formulation
ZA876959B (en) Pharmaceutical formulations
GB8603097D0 (en) Pharmaceutical formulations